Dan Li DaFu Yang SaiQiong Cui Evenki Pan Peng Yang ZhaoXia Dai
10.2147/OTT.S318250
Onco Targets Ther
2021 Jul 21;14:4261-4265.
egfr mutation acquired resistance circulating tumor dna lung adenocarcinoma osimertinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34321891/
Case Reports
PMC8312323
34321891
NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma
2021